Nicholas Investment Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-18,624
Closed -$5.32M 241
2019
Q1
$5.32M Sell
18,624
-9,360
-33% -$3.11M 0.47% 61
2018
Q4
$9.1M Buy
27,984
+2,984
+12% +$1.04M 0.98% 14
2018
Q3
$11.2M Sell
25,000
-31,372
-56% -$12.4M 0.9% 17
2018
Q2
$23.1M Sell
56,372
-2,961
-5% -$1.07M 1.62% 4
2018
Q1
$17.3M Sell
59,333
-9,484
-14% -$2.4M 1.23% 5
2017
Q4
$12.9M Sell
68,817
-2,297
-3% -$429K 0.85% 12
2017
Q3
$12M Sell
71,114
-598
-0.8% -$90.4K 0.83% 10
2017
Q2
$10.3M Buy
71,712
+30,235
+73% +$4.06M 0.73% 15
2017
Q1
$5.19M Buy
41,477
+929
+2% +$108K 0.37% 86
2016
Q4
$4.57M Sell
40,548
-24,089
-37% -$2.79M 0.35% 105
2016
Q3
$8.31M Sell
64,637
-4,415
-6% -$529K 0.55% 34
2016
Q2
$7.55M Buy
69,052
+36,566
+113% +$3.64M 0.52% 43
2016
Q1
$3.08M Sell
32,486
-54,346
-63% -$4.59M 0.23% 180
2015
Q4
$7.84M Buy
86,832
+39,170
+82% +$3.32M 0.54% 42
2015
Q3
$4.42M Sell
47,662
-8,185
-15% -$721K 0.32% 123
2015
Q2
$3.67M Buy
55,847
+32,068
+135% +$2.13M 0.24% 170
2015
Q1
$1.7M Buy
+23,779
New +$1.29M 0.11% 271
2014
Q2
Sell
-79,554
Closed -$2.07M 309
2014
Q1
$2.07M Sell
79,554
-46,804
-37% -$1.29M 0.17% 204
2013
Q4
$3.38M Buy
+126,358
New +$3.12M 0.26% 92

Other funds holding ABMD

Nicholas Investment Partners's ABMD Position: Q2 2019 in Review

Nicholas Investment Partners sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 18,624 shares — an estimated $5.32M sold.

Nicholas Investment Partners first reported a position in ABMD in Q4 2013 and held it in 19 quarters. The position peaked at $23.1M in Q2 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Nicholas Investment Partners reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Nicholas Investment Partners sold 18,624 Abiomed Inc shares in Q2 2019, an estimated $5.32M.
  • Nicholas Investment Partners first reported a position in Abiomed Inc in Q4 2013 and held it in 19 quarters.
  • Nicholas Investment Partners's Abiomed Inc position peaked at $23.1M in Q2 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Nicholas Investment Partners's 13F filing for Q2 2019, filed 9 Aug 2019.